Clinical Trial Update: An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AZR-MD-001 for Meibomian Gland Dysfunction and Contact Lens Discomfort has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contact Lens Discomfort
• Meibomian Gland Dysfunction

Drugs mentioned

• AZR-MD-001

Snippet

Sponsor: Azura Ophthalmics | Conditions: Meibomian Gland Dysfunction (MGD), Contact Lens Discomfort (CLD) | Phase 2 | Status: COMPLETED | Results posted: 2023-01-25